Step by Step

INTRODUCTION

ABIM MOC Activity ID

11/21/2017 - Medical Grand Rounds: Big Data and IBD: Defining clinical challenges and developing data driven solutions

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Describe disease severity in the IBD patient population results from heterogeneous factors and can be characterized by patterns of healthcare utilization and healthcare charges over a multi-year time period.
  • Explain how monitoring telephone activity in the electronic health records identifies IBD patients at risk for high healthcare utilization and charges.
  • Recognize peripheral blood eosinophilia is a novel biomarker of severity in patients with IBD.

Suggested Additional Reading:

  1. C Ramos-Rivers, M Regueiro, EJ Vargas, E Szigethy, RE Schoen, M Dunn, AR Watson, M Schwartz,J Swoger, L Baidoo, A Barrie, A Dudekula, AO Youk, DG Binion. Association Between Telephone Activity and Features of Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2014; 12: 986-94. PMID:24262938
  2. Jiang J, Click B, Anderson AM, Koutroubakis IE, Rivers CR, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A, Regueiro M, Chang CC, Binion DG. Group-Based Trajectory Modeling of Healthcare Financial Charges in Inflammatory Bowel Disease: A Comprehensive Phenotype. Clin Transl Gastroenterol. 2016 Jul 14;7(7):e181. PMID: 27415619
  3. Click B, Anderson AM, Ramos Rivers C, Koutroubakis IE, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A 3rd, Szigethy E, Regueiro M, Schoen RE, Binion DG. Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study. J Clin Gastroenterol. 2017 Apr 27. doi: 10.1097/MCG.0000000000000801. [Epub ahead of print] PMID: 28452828
  4. Click B, Anderson AM, Koutroubakis IE, Rivers CR, Babichenko D, Machicado JD, Hartman DJ, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie Iii A, Wenzel SE, Regueiro M, Binion DG. Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype. Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.402. [Epub ahead of print] PMID: 29112200

Authors:
David G. Binion, MD., AGAF, FACG — Professor of Medicine, Clinical and Translational Science
Dr. Binion receives honoraria/consulting from Abbvie. He is on the steering committee for FDA mandated safety registry and USB Pharma. Dr. Binion receives grant support from the Department of Defense, CDMRP, NIH T32, Merck, Shire and Takeda.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.